An A13 repeat within the 3’UTR of EGFR is frequently mutated in MSI colon cancers and is associated with increased EGFR expression

Colorectal cancers with microsatellite instability (MSI) have clinical, pathological, genetic, and epigenetic features distinct from microsatellite stable (MSS) CRC. Examination of EGFR mRNA and protein expression levels in a panel of colon cancer cell lines identified strong expression of EGFR in m...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 2009-09, Vol.69 (19), p.7811-7818
Main Authors: Yuan, Ziqiang, Shin, Joongho, Wilson, Andrew, Goel, Sanjay, Ling, Yi-He, Ahmed, Naseem, Dopeso, Higinio, Jhawer, Minaxi, Nasser, Shannon, Montagna, Cristina, Fordyce, Kenneth, Augenlicht, Leonard H., Aaltonen, Lauri A., Arango, Diego, Weber, Thomas K., Mariadason, John M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 7818
container_issue 19
container_start_page 7811
container_title Cancer research (Chicago, Ill.)
container_volume 69
creator Yuan, Ziqiang
Shin, Joongho
Wilson, Andrew
Goel, Sanjay
Ling, Yi-He
Ahmed, Naseem
Dopeso, Higinio
Jhawer, Minaxi
Nasser, Shannon
Montagna, Cristina
Fordyce, Kenneth
Augenlicht, Leonard H.
Aaltonen, Lauri A.
Arango, Diego
Weber, Thomas K.
Mariadason, John M.
description Colorectal cancers with microsatellite instability (MSI) have clinical, pathological, genetic, and epigenetic features distinct from microsatellite stable (MSS) CRC. Examination of EGFR mRNA and protein expression levels in a panel of colon cancer cell lines identified strong expression of EGFR in multiple cell lines with microsatellite instability. While no relationship between EGFR overexpression and the length of a CA dinucleotide repeat in intron 1 was observed, a variant A13/A14 repeat sequence within the 3’-UTR of the EGFR gene was identified which was mutated by either mono or dinucleotide adenosine deletions in 64% of MSI cell lines, and 69% of MSI colon tumors. Utilizing a Tet-Off system we demonstrate that this mutation increases EGFR mRNA stability in colon cancer cells, providing a mechanistic basis for EGFR over-expression in MSI colon cancer cell lines. To determine whether this mutation is a driver or a bystander event in MSI colon cancer, we examined the effect of pharmacological and molecular inhibition of EGFR in EGFR 3’UTR mutant MSI cell lines. Cell lines with an EGFR 3’UTR mutation and which were wild type for downstream signaling mediators in the Ras/BRAF and PIK3CA/PTEN pathways were sensitive to EGFR inhibition, while those harboring mutations in these signaling mediators were not. Furthermore, in cell lines wild type for downstream signaling mediators, those with EGFR 3’UTR mutations were more sensitive to EGFR inhibition than EGFR 3’UTR WT cells, suggesting this mutation provides a growth advantage to this subset of MSI colon tumors.
doi_str_mv 10.1158/0008-5472.CAN-09-0986
format article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2785717</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_2785717</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_27857173</originalsourceid><addsrcrecordid>eNqljc1KxDAUhYMoTv15BOG-QMdk2ph0IwzDzOhCF-O4LjFNbaRNapKqs3PhS_h6PomZQQTXwoHL4X58B6EzgseEUH6OMeYpzdlkPJvepriI4Rd7KCE04ynLc7qPkl9mhI68f4qVEkwP0YgUjBdZzhL0MTUwJRk41SsR4FWHRhsIjYLs6_3zfr0CW8N8uViB9lA79TwoE9oNdEMQQVUQ4Zu7a5C2tQakMFI5D8JUW1x4b6XeYVtvZKVTwse6E6q33invtTUn6KAWrVenP_cYXS7m69lV2g8PnapknHSiLXunO-E2pRW6_Psxuikf7Us5YZwywrJ_C74Bpqpw_A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>An A13 repeat within the 3’UTR of EGFR is frequently mutated in MSI colon cancers and is associated with increased EGFR expression</title><source>EZB Electronic Journals Library</source><creator>Yuan, Ziqiang ; Shin, Joongho ; Wilson, Andrew ; Goel, Sanjay ; Ling, Yi-He ; Ahmed, Naseem ; Dopeso, Higinio ; Jhawer, Minaxi ; Nasser, Shannon ; Montagna, Cristina ; Fordyce, Kenneth ; Augenlicht, Leonard H. ; Aaltonen, Lauri A. ; Arango, Diego ; Weber, Thomas K. ; Mariadason, John M.</creator><creatorcontrib>Yuan, Ziqiang ; Shin, Joongho ; Wilson, Andrew ; Goel, Sanjay ; Ling, Yi-He ; Ahmed, Naseem ; Dopeso, Higinio ; Jhawer, Minaxi ; Nasser, Shannon ; Montagna, Cristina ; Fordyce, Kenneth ; Augenlicht, Leonard H. ; Aaltonen, Lauri A. ; Arango, Diego ; Weber, Thomas K. ; Mariadason, John M.</creatorcontrib><description>Colorectal cancers with microsatellite instability (MSI) have clinical, pathological, genetic, and epigenetic features distinct from microsatellite stable (MSS) CRC. Examination of EGFR mRNA and protein expression levels in a panel of colon cancer cell lines identified strong expression of EGFR in multiple cell lines with microsatellite instability. While no relationship between EGFR overexpression and the length of a CA dinucleotide repeat in intron 1 was observed, a variant A13/A14 repeat sequence within the 3’-UTR of the EGFR gene was identified which was mutated by either mono or dinucleotide adenosine deletions in 64% of MSI cell lines, and 69% of MSI colon tumors. Utilizing a Tet-Off system we demonstrate that this mutation increases EGFR mRNA stability in colon cancer cells, providing a mechanistic basis for EGFR over-expression in MSI colon cancer cell lines. To determine whether this mutation is a driver or a bystander event in MSI colon cancer, we examined the effect of pharmacological and molecular inhibition of EGFR in EGFR 3’UTR mutant MSI cell lines. Cell lines with an EGFR 3’UTR mutation and which were wild type for downstream signaling mediators in the Ras/BRAF and PIK3CA/PTEN pathways were sensitive to EGFR inhibition, while those harboring mutations in these signaling mediators were not. Furthermore, in cell lines wild type for downstream signaling mediators, those with EGFR 3’UTR mutations were more sensitive to EGFR inhibition than EGFR 3’UTR WT cells, suggesting this mutation provides a growth advantage to this subset of MSI colon tumors.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-09-0986</identifier><identifier>PMID: 19789347</identifier><language>eng</language><ispartof>Cancer research (Chicago, Ill.), 2009-09, Vol.69 (19), p.7811-7818</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,27957,27958</link.rule.ids></links><search><creatorcontrib>Yuan, Ziqiang</creatorcontrib><creatorcontrib>Shin, Joongho</creatorcontrib><creatorcontrib>Wilson, Andrew</creatorcontrib><creatorcontrib>Goel, Sanjay</creatorcontrib><creatorcontrib>Ling, Yi-He</creatorcontrib><creatorcontrib>Ahmed, Naseem</creatorcontrib><creatorcontrib>Dopeso, Higinio</creatorcontrib><creatorcontrib>Jhawer, Minaxi</creatorcontrib><creatorcontrib>Nasser, Shannon</creatorcontrib><creatorcontrib>Montagna, Cristina</creatorcontrib><creatorcontrib>Fordyce, Kenneth</creatorcontrib><creatorcontrib>Augenlicht, Leonard H.</creatorcontrib><creatorcontrib>Aaltonen, Lauri A.</creatorcontrib><creatorcontrib>Arango, Diego</creatorcontrib><creatorcontrib>Weber, Thomas K.</creatorcontrib><creatorcontrib>Mariadason, John M.</creatorcontrib><title>An A13 repeat within the 3’UTR of EGFR is frequently mutated in MSI colon cancers and is associated with increased EGFR expression</title><title>Cancer research (Chicago, Ill.)</title><description>Colorectal cancers with microsatellite instability (MSI) have clinical, pathological, genetic, and epigenetic features distinct from microsatellite stable (MSS) CRC. Examination of EGFR mRNA and protein expression levels in a panel of colon cancer cell lines identified strong expression of EGFR in multiple cell lines with microsatellite instability. While no relationship between EGFR overexpression and the length of a CA dinucleotide repeat in intron 1 was observed, a variant A13/A14 repeat sequence within the 3’-UTR of the EGFR gene was identified which was mutated by either mono or dinucleotide adenosine deletions in 64% of MSI cell lines, and 69% of MSI colon tumors. Utilizing a Tet-Off system we demonstrate that this mutation increases EGFR mRNA stability in colon cancer cells, providing a mechanistic basis for EGFR over-expression in MSI colon cancer cell lines. To determine whether this mutation is a driver or a bystander event in MSI colon cancer, we examined the effect of pharmacological and molecular inhibition of EGFR in EGFR 3’UTR mutant MSI cell lines. Cell lines with an EGFR 3’UTR mutation and which were wild type for downstream signaling mediators in the Ras/BRAF and PIK3CA/PTEN pathways were sensitive to EGFR inhibition, while those harboring mutations in these signaling mediators were not. Furthermore, in cell lines wild type for downstream signaling mediators, those with EGFR 3’UTR mutations were more sensitive to EGFR inhibition than EGFR 3’UTR WT cells, suggesting this mutation provides a growth advantage to this subset of MSI colon tumors.</description><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqljc1KxDAUhYMoTv15BOG-QMdk2ph0IwzDzOhCF-O4LjFNbaRNapKqs3PhS_h6PomZQQTXwoHL4X58B6EzgseEUH6OMeYpzdlkPJvepriI4Rd7KCE04ynLc7qPkl9mhI68f4qVEkwP0YgUjBdZzhL0MTUwJRk41SsR4FWHRhsIjYLs6_3zfr0CW8N8uViB9lA79TwoE9oNdEMQQVUQ4Zu7a5C2tQakMFI5D8JUW1x4b6XeYVtvZKVTwse6E6q33invtTUn6KAWrVenP_cYXS7m69lV2g8PnapknHSiLXunO-E2pRW6_Psxuikf7Us5YZwywrJ_C74Bpqpw_A</recordid><startdate>20090929</startdate><enddate>20090929</enddate><creator>Yuan, Ziqiang</creator><creator>Shin, Joongho</creator><creator>Wilson, Andrew</creator><creator>Goel, Sanjay</creator><creator>Ling, Yi-He</creator><creator>Ahmed, Naseem</creator><creator>Dopeso, Higinio</creator><creator>Jhawer, Minaxi</creator><creator>Nasser, Shannon</creator><creator>Montagna, Cristina</creator><creator>Fordyce, Kenneth</creator><creator>Augenlicht, Leonard H.</creator><creator>Aaltonen, Lauri A.</creator><creator>Arango, Diego</creator><creator>Weber, Thomas K.</creator><creator>Mariadason, John M.</creator><scope>5PM</scope></search><sort><creationdate>20090929</creationdate><title>An A13 repeat within the 3’UTR of EGFR is frequently mutated in MSI colon cancers and is associated with increased EGFR expression</title><author>Yuan, Ziqiang ; Shin, Joongho ; Wilson, Andrew ; Goel, Sanjay ; Ling, Yi-He ; Ahmed, Naseem ; Dopeso, Higinio ; Jhawer, Minaxi ; Nasser, Shannon ; Montagna, Cristina ; Fordyce, Kenneth ; Augenlicht, Leonard H. ; Aaltonen, Lauri A. ; Arango, Diego ; Weber, Thomas K. ; Mariadason, John M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_27857173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yuan, Ziqiang</creatorcontrib><creatorcontrib>Shin, Joongho</creatorcontrib><creatorcontrib>Wilson, Andrew</creatorcontrib><creatorcontrib>Goel, Sanjay</creatorcontrib><creatorcontrib>Ling, Yi-He</creatorcontrib><creatorcontrib>Ahmed, Naseem</creatorcontrib><creatorcontrib>Dopeso, Higinio</creatorcontrib><creatorcontrib>Jhawer, Minaxi</creatorcontrib><creatorcontrib>Nasser, Shannon</creatorcontrib><creatorcontrib>Montagna, Cristina</creatorcontrib><creatorcontrib>Fordyce, Kenneth</creatorcontrib><creatorcontrib>Augenlicht, Leonard H.</creatorcontrib><creatorcontrib>Aaltonen, Lauri A.</creatorcontrib><creatorcontrib>Arango, Diego</creatorcontrib><creatorcontrib>Weber, Thomas K.</creatorcontrib><creatorcontrib>Mariadason, John M.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yuan, Ziqiang</au><au>Shin, Joongho</au><au>Wilson, Andrew</au><au>Goel, Sanjay</au><au>Ling, Yi-He</au><au>Ahmed, Naseem</au><au>Dopeso, Higinio</au><au>Jhawer, Minaxi</au><au>Nasser, Shannon</au><au>Montagna, Cristina</au><au>Fordyce, Kenneth</au><au>Augenlicht, Leonard H.</au><au>Aaltonen, Lauri A.</au><au>Arango, Diego</au><au>Weber, Thomas K.</au><au>Mariadason, John M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An A13 repeat within the 3’UTR of EGFR is frequently mutated in MSI colon cancers and is associated with increased EGFR expression</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><date>2009-09-29</date><risdate>2009</risdate><volume>69</volume><issue>19</issue><spage>7811</spage><epage>7818</epage><pages>7811-7818</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><notes>These authors contributed equally.</notes><notes>Current address: Ludwig Institute for Cancer Research, Melbourne, Australia.</notes><abstract>Colorectal cancers with microsatellite instability (MSI) have clinical, pathological, genetic, and epigenetic features distinct from microsatellite stable (MSS) CRC. Examination of EGFR mRNA and protein expression levels in a panel of colon cancer cell lines identified strong expression of EGFR in multiple cell lines with microsatellite instability. While no relationship between EGFR overexpression and the length of a CA dinucleotide repeat in intron 1 was observed, a variant A13/A14 repeat sequence within the 3’-UTR of the EGFR gene was identified which was mutated by either mono or dinucleotide adenosine deletions in 64% of MSI cell lines, and 69% of MSI colon tumors. Utilizing a Tet-Off system we demonstrate that this mutation increases EGFR mRNA stability in colon cancer cells, providing a mechanistic basis for EGFR over-expression in MSI colon cancer cell lines. To determine whether this mutation is a driver or a bystander event in MSI colon cancer, we examined the effect of pharmacological and molecular inhibition of EGFR in EGFR 3’UTR mutant MSI cell lines. Cell lines with an EGFR 3’UTR mutation and which were wild type for downstream signaling mediators in the Ras/BRAF and PIK3CA/PTEN pathways were sensitive to EGFR inhibition, while those harboring mutations in these signaling mediators were not. Furthermore, in cell lines wild type for downstream signaling mediators, those with EGFR 3’UTR mutations were more sensitive to EGFR inhibition than EGFR 3’UTR WT cells, suggesting this mutation provides a growth advantage to this subset of MSI colon tumors.</abstract><pmid>19789347</pmid><doi>10.1158/0008-5472.CAN-09-0986</doi></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2009-09, Vol.69 (19), p.7811-7818
issn 0008-5472
1538-7445
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2785717
source EZB Electronic Journals Library
title An A13 repeat within the 3’UTR of EGFR is frequently mutated in MSI colon cancers and is associated with increased EGFR expression
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T01%3A51%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20A13%20repeat%20within%20the%203%E2%80%99UTR%20of%20EGFR%20is%20frequently%20mutated%20in%20MSI%20colon%20cancers%20and%20is%20associated%20with%20increased%20EGFR%20expression&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Yuan,%20Ziqiang&rft.date=2009-09-29&rft.volume=69&rft.issue=19&rft.spage=7811&rft.epage=7818&rft.pages=7811-7818&rft.issn=0008-5472&rft.eissn=1538-7445&rft_id=info:doi/10.1158/0008-5472.CAN-09-0986&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_2785717%3C/pubmedcentral%3E%3Cgrp_id%3Ecdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_27857173%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19789347&rfr_iscdi=true